Überprüfung…
Automatisch übersetzt. Dosierung und Warnhinweise: bitte im englischen Original prüfen. Auf Englisch lesen
Homepage / Eingetragen in Nigeria / Paraflex Tablets

Paraflex Tablets

NAFDAC Reg.-Nr. A4-8018 Medikament

Registriert bei NAFDAC. Registrierung aktivAs of 31 October 2026 · synced automatically from official sources.
Produkt-
Paraflex Tablets
NAFDAC-Nummer
A4-8018
Wirkstoff
Chlorzoxazone; Paracetamol
Stärke
250 mg; 500 mg
Form
Tablet
Hersteller
Not listed
Applicant (holder)
Franphino Pharmaceuticals Nigeria Limited
Approved
21 Dec 2020
Status
Inactive View on NAFDAC ↗
Registration valid to
20 Dec 2025
WER WARNT
None found
Community reports
None
Times checked
0

About the medicine: Chlorzoxazone: uses, dosage and brands worldwide

What we found

  • Paraflex Tablets is on the NAFDAC register with an active registration (A4-8018). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. This is not medical advice. Always follow your doctor or pharmacist.

How to use Paraflex Tablets

What the official label says. If a doctor prescribed it, follow the prescription. Your pack's leaflet comes first if it is different.

Who it is for

INDICATIONS Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man.

How to take it and how often
  • Usual Adult Dosage One tablet three or four times daily
  • If adequate response is not obtained with this dose, it may be increased to one and one-half tablets (750 mg) three or four times daily
  • As improvement occurs dosage can usually be reduced
Talk to a doctor first if

Chlorzoxazone is contraindicated in patients with known intolerance to the drug.

Warnings

Serious (including fatal) hepatocellular toxicity has been reported rarely in patients receiving chlorzoxazone. The mechanism is unknown but appears to be idiosyncratic and unpredictable. Factors predisposing patients to this rare event are not known. Patients should be instructed to report early signs and/or symptoms of hepatotoxicity such as fever, rash, anorexia, nausea, vomiting, fatigue, right upper quadrant pain, dark urine, or jaundice. Chlorzoxazone should be discontinued immediately and a physician consulted if any of these signs or symptoms develop. …

Possible side effects

Chlorzoxazone containing products are usually well tolerated. It is possible in rare instances that chlorzoxazone may have been associated with gastrointestinal bleeding. Drowsiness, dizziness, lightheadedness, malaise, or over-stimulation may be noted by an occasional patient. Rarely, allergic type skin rashes, petechiae, or ecchymoses may develop during treatment. Angioneurotic edema or anaphylactic reactions are extremely rare. There is no evidence that the drug will cause renal damage. Rarely, a patient may note discoloration of the urine resulting from a phenolic metabolite of chlorzoxazone. This finding is of no known clinical significance. …

If you take too much

Symptoms Initially, gastrointestinal disturbances such as nausea, vomiting, or diarrhea together with drowsiness, dizziness, lightheadedness or headache may occur. Early in the course there may be malaise or sluggishness followed by marked loss of muscle tone, making voluntary movement impossible. The deep tendon reflexes may be decreased or absent. The sensorium remains intact, and there is no peripheral loss of sensation. Respiratory depression may occur with rapid, irregular respiration and intercostal and substernal retraction. …

If you miss a dose

Take it when you remember, unless it is nearly time for the next dose. Then skip the missed one. Never take two doses at once to make up for it. Check your leaflet, as some medicines are different.

From the official U.S. FDA label for this active ingredient. Your pack may have a different strength, so always read its leaflet. If a doctor prescribed it, follow the prescription. Ask a pharmacist if you are unsure. Label dated 2025-03-01.

Label for chlorzoxazone and paracetamol, the active ingredient registered with NAFDAC.

Check your pack of Paraflex Tablets

Add the expiry date on your pack for a full Trust Score.

Or take photos of the pack
3 free checks left today Official sources: U.S. FDA · EMA (EU) · NAFDAC · WHO alerts

About Paraflex Tablets

What is in Paraflex Tablets?

Paraflex Tablets contains Chlorzoxazone; Paracetamol (250 mg; 500 mg), as tablet, according to its NAFDAC registration record.

Is Paraflex Tablets registered with NAFDAC?

Yes. Paraflex Tablets is listed on the NAFDAC register under registration number A4-8018, and its registration is active as of 31 October 2026.

Has Paraflex Tablets been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Paraflex Tablets in our automatically synced alert list.

How can I check that my pack of Paraflex Tablets is genuine?

Run a free authenticity scan with the NAFDAC number A4-8018, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

How do I take Paraflex Tablets?

Follow your prescription or the leaflet in your pack. The official label says: Usual Adult Dosage One tablet three or four times daily. If adequate response is not obtained with this dose, it may be increased to one and one-half tablets (750 mg) three or four times daily. As improvement occurs dosage can usually be reduced.…

What is Paraflex Tablets used for?

INDICATIONS Chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Chlorzoxazone does not directly relax tense skeletal muscles in man. (Summarised from the official U.S. FDA label for chlorzoxazone and paracetamol. Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Paraflex Tablets? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from PillVera users, not medical advice. Report side effects to your doctor and to NAFDAC.